State Street’s Sucampo Pharmaceuticals, Inc. SCMP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q1 | – | Sell |
-824,588
| Closed | -$14.8M | – | 3827 |
|
|
2017
Q4 | $14.8M | Buy |
824,588
+215,006
| +35% | +$2.65M | ﹤0.01% | 2255 |
|
|
2017
Q3 | $7.2M | Buy |
609,582
+10,162
| +2% | +$114K | ﹤0.01% | 2602 |
|
|
2017
Q2 | $6.29M | Buy |
599,420
+40,929
| +7% | +$417K | ﹤0.01% | 2627 |
|
|
2017
Q1 | $6.15M | Sell |
558,491
-23,344
| -4% | -$271K | ﹤0.01% | 2604 |
|
|
2016
Q4 | $7.88M | Buy |
581,835
+143,906
| +33% | +$2.01M | ﹤0.01% | 2452 |
|
|
2016
Q3 | $5.39M | Buy |
437,929
+10,402
| +2% | +$123K | ﹤0.01% | 2517 |
|
|
2016
Q2 | $4.69M | Sell |
427,527
-8,206
| -2% | -$91.9K | ﹤0.01% | 2620 |
|
|
2016
Q1 | $4.76M | Sell |
435,733
-687,430
| -61% | -$8.69M | ﹤0.01% | 2572 |
|
|
2015
Q4 | $19.4M | Sell |
1,123,163
-349,914
| -24% | -$6.27M | ﹤0.01% | 1735 |
|
|
2015
Q3 | $29.3M | Buy |
1,473,077
+1,163,385
| +376% | +$26.7M | ﹤0.01% | 1496 |
|
|
2015
Q2 | $5.09M | Buy |
309,692
+51,818
| +20% | +$898K | ﹤0.01% | 2613 |
|
|
2015
Q1 | $4.02M | Buy |
257,874
+24,345
| +10% | +$377K | ﹤0.01% | 2691 |
|
|
2014
Q4 | $3.33M | Buy |
233,529
+14,166
| +6% | +$150K | ﹤0.01% | 2788 |
|
|
2014
Q3 | $1.43M | Buy |
219,363
+2,489
| +1% | +$16.5K | ﹤0.01% | 3153 |
|
|
2014
Q2 | $1.5M | Buy |
216,874
+8,465
| +4% | +$59.9K | ﹤0.01% | 3156 |
|
|
2014
Q1 | $1.49M | Buy |
208,409
+30,110
| +17% | +$258K | ﹤0.01% | 3165 |
|
|
2013
Q4 | $1.68M | Buy |
178,299
+387
| +0.2% | +$2.76K | ﹤0.01% | 3135 |
|
|
2013
Q3 | $1.11M | Sell |
177,912
-12,355
| -6% | -$77.2K | ﹤0.01% | 3230 |
|
|
2013
Q2 | $1.25M | Buy |
+190,267
| New | +$1.51M | ﹤0.01% | 3151 |
|
Other funds holding SCMP
State Street's SCMP Position: Q1 2018 in Review
State Street sold out of Sucampo Pharmaceuticals, Inc. (SCMP) in Q1 2018, closing a stake of 824,588 shares — an estimated $14.8M sold.
State Street first reported a position in SCMP in Q2 2013 and held it in 19 quarters. The position peaked at $29.3M in Q3 2015. 3 funds tracked by Wall St. Rank hold SCMP as of Q1 2018.
- State Street reported no remaining Sucampo Pharmaceuticals, Inc. position as of Q1 2018 after selling out during the quarter.
- State Street sold 824,588 Sucampo Pharmaceuticals, Inc. shares in Q1 2018, an estimated $14.8M.
- State Street first reported a position in Sucampo Pharmaceuticals, Inc. in Q2 2013 and held it in 19 quarters.
- State Street's Sucampo Pharmaceuticals, Inc. position peaked at $29.3M in Q3 2015.
- 3 funds tracked by Wall St. Rank held Sucampo Pharmaceuticals, Inc. as of Q1 2018.
Based on State Street's 13F filing for Q1 2018, filed 15 May 2018.